Luceiro Capital Companies

ESEN

Real companies with freely usable public data: official annual reports of European listed companies (ESEF), SEC accounts and ECB exchange rates. No share prices, so there is no market capitalisation, P/E or EV/EBITDA.

Company sheet · analysis as of 21/10/2026

Stryker Corporation

SYK · Health care · Medical technology · US · reporting currency USD · LEI 5493002F0SC4JTBU5137

Share: XNYS · USD · US8636671013 · Price: No data: no share prices up to the analysis date

Reference period: H1 ended 30/06/2026, published on 31/07/2026

← Back to the ranking

Shareholder score without valuation

59

Coverage 100 %

Credit score

62

Coverage 100 %

Alerts

0

Screens passed: 1 of 1

Shareholder view

FactorValueCompared with PercentileWeightContribution
ROE 15.5 % Sector (6 companies) 58 17 % 9.7
ROIC 11.7 % Sector (7 companies) 50 17 % 8.3
Gross margin 65.0 % Universe (26 companies) 83 17 % 13.8
EBITDA margin 27.7 % Sector (7 companies) 50 17 % 8.3
Cash conversion 126.1 % Sector (7 companies) 64 17 % 10.7
Revenue growth 8.5 % Sector (7 companies) 50 17 % 8.3
Formulas and inputs

ROE: LTM attributable net income / Attributable equity at period end

LTM attributable net income
3,729.0
Attributable equity
23,988.0

ROIC: LTM EBIT × (1 − notional tax rate) / (Total equity + Financial debt − Cash)

LTM EBIT
5,534.0
Total equity
23,988.0
Financial debt
14,942.0
Cash and equivalents
3,391.0
Notional tax rate
0.2500

Gross margin: LTM gross profit / LTM revenue

LTM gross profit
16,788.0
LTM revenue
25,837.0

EBITDA margin: LTM EBITDA / LTM revenue

LTM EBITDA
7,152.0
LTM revenue
25,837.0

Cash conversion: (LTM operating cash flow − LTM capex) / LTM net income attributable

LTM operating cash flow
5,525.0
LTM capital expenditure (capex)
823.00
LTM attributable net income
3,729.0

Revenue growth: LTM revenue / LTM revenue a year earlier − 1

LTM revenue
25,837.0
Prior-year LTM revenue
23,818.0

Amounts in euros

Market capitalisation No data
Enterprise value (EV) No data
LTM revenue 22,155 M EUR
LTM EBITDA 6,133 M EUR
Net debt 10,138 M EUR

Creditor view

FactorValueCompared with PercentileWeightContribution
Net debt/EBITDA 1.6x Sector (7 companies) 64 33 % 21.4
Interest coverage 11.9x Sector (7 companies) 64 33 % 21.4
Debt/equity 0.6x Sector (6 companies) 58 33 % 19.4
Formulas and inputs

Net debt/EBITDA: (Financial debt − Cash) / LTM EBITDA

Financial debt
14,942.0
Cash and equivalents
3,391.0
LTM EBITDA
7,152.0

Interest coverage: LTM EBITDA / LTM interest expense

LTM EBITDA
7,152.0
LTM interest expense
600.00

Debt/equity: Financial debt / Total equity

Financial debt
14,942.0
Total equity
23,988.0

Outstanding bonds

The loaded data contain no outstanding bonds of this company.

Alerts

No alerts in this run.

Screens

ScreenResultConditions
Moderate leverage Passes Net debt/EBITDA ≤ 2.5x: value: 1.6x
Interest coverage ≥ 5.0x: value: 11.9x

Annual history (millions of USD)

2023
FY 31/12/2023
2024
FY 31/12/2024
2025
FY 31/12/2025
Revenue20,49822,59525,116
EBITDA5,2295,1156,459
Attributable net income3,1652,9933,246
Free cash flow3,1363,4874,283
Net debt10,0249,94511,848

Each fiscal year is labelled with the calendar year in which most of its months fall.

The scores summarise metrics compared with similar companies, and the alerts point to specific facts. Nothing shown here is a recommendation to buy or sell.